SHAMAL

What's involved: A Multicentre, Randomised, Open-Label, Parallel-Group, Active-Controlled, Phase IV Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients with Severe Eosinophilic Asthma Treated with Benralizumab
Take part: Suspended
Principal Investigator: Professor Tim Harrison

Research Theme | Respiratory

What's involved

A Multicentre, Randomised, Open-Label, Parallel-Group, Active-Controlled, Phase IV Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients with Severe Eosinophilic Asthma Treated with Benralizumab

Principal Investigator

Professor Tim Harrison

Take part

Suspended

Back to all trials

What's involved

Principal Investigator

Take part

Contact Us

Hosted by